Page last updated: 2024-08-23

agreal and Parkinsonian Disorders

agreal has been researched along with Parkinsonian Disorders in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bergareche, A; López de Munain, A; Martí Massó, JF; Ruiz-Martínez, J	1
De Leo, V; Delia, A; Faldini, E; Morgante, G; Musacchio, MC; Petraglia, F	1

Reviews

1 review(s) available for agreal and Parkinsonian Disorders

Article	Year
The safety of veralipride. Expert opinion on drug safety, 2006, Volume: 5, Issue:5 Topics: Adult; Aged; Basal Ganglia Diseases; Dopamine D2 Receptor Antagonists; Estrogens; Female; Half-Life; Hot Flashes; Humans; Middle Aged; Parkinsonian Disorders; Randomized Controlled Trials as Topic; Risk Assessment; Safety; Sulpiride	2006

Other Studies

1 other study(ies) available for agreal and Parkinsonian Disorders

Article	Year
[Parkinsonism induced by sulpiride and veralipride: two different stories]. Medicina clinica, 2011, Oct-15, Volume: 137, Issue:10 Topics: Adult; Aged; Brain Damage, Chronic; Contraindications; Dyskinesia, Drug-Induced; Europe; Female; Humans; Male; Middle Aged; Molecular Structure; Nervous System Diseases; Parkinson Disease; Parkinsonian Disorders; Retrospective Studies; Safety-Based Drug Withdrawals; Spain; Structure-Activity Relationship; Sulpiride; Torticollis	2011

Article

Year

[Parkinsonism induced by sulpiride and veralipride: two different stories].

Medicina clinica, 2011, Oct-15, Volume: 137, Issue:10

Topics: Adult; Aged; Brain Damage, Chronic; Contraindications; Dyskinesia, Drug-Induced; Europe; Female; Humans; Male; Middle Aged; Molecular Structure; Nervous System Diseases; Parkinson Disease; Parkinsonian Disorders; Retrospective Studies; Safety-Based Drug Withdrawals; Spain; Structure-Activity Relationship; Sulpiride; Torticollis

2011